Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
Additionally, throughout the Class Period, Caribou made materially false and misleading statements regarding the company’s business, operations, and prospects.